Table 1 Characteristics of the included studies
Study | Year | Design* | Number of patients | Patients demographics (male/female) | Age (range) | Age (mean) | Number of prostheses | Reference standard | Number of hip prostheses (total/infected) |
|---|---|---|---|---|---|---|---|---|---|
Rand & Brown [38] | 1990 | Retrospective | 38 | 16/22 | 26–86 | 65.0 | 38 knee | M, H, IOF | 38/18 |
Palestro et al.[34] | 1991 | Retrospective | 28 | 7/21 | 23–85 | 65.0 | 32 knee | M, IOF, CFU | 32/9 |
Ooi et al. [28] | 1993 | NR | 19 | 11/8 | 25–84 | NR | 6 knee | M, H, IOF, CFU | 6/3 |
Nijhof et al. [27] | 1997 | NR | 226 | 108/118 | 5–90 | 54.0 | 87 hip, 17 knee | M, IOF, CFU | 17/3 |
Scher et al. [41] | 2000 | NR | 143 | NR | 26–87 | 61.0 | 91 hip, 40 knee | M, H, IOF | 40/14 |
van Acker et al. [50] | 2001 | Prospective | 21 | 8/13 | 33–78 | 66.0 | 22 knee | M, CFU | 22/6 |
Joseph et al. [16] | 2001 | Retrospective | 58 | 18/40 | 27–82 | 60.0 | 36 hip, 22 knee | M, H, IOF | 22/6 |
Larikka et al. [20] | 2001 | Prospective | 28 | 4/24 | 47–82 | 75.0 | 30 knee | M, IOF | 30/8 |
Zhuang et al. [56] | 2001 | NR | 62 | NR | 27–81 | NR | 38 hip, 36 knee | M, IOF, A, CFU | 36/11 |
Ivancevic et al. [14] | 2002 | Retrospective | 30 | 13/17 | 30–85 | Median 62.0 | 21 hip, 6 knee | M, H | 6/2 |
El Espera et al.[7] | 2004 | NR | 60 | NR | NR | NR | 45 hip, 28 knee | M, IOF, A | 28/7 |
Love et al. [21] | 2004 | NR | 59 | 22/37 | 35–89 | NR | 40 hip, 19 knee | M, H, IOF | 19/11 |
Pelosi et al. [37] | 2004 | Retrospective | 78 | 36/42 | 30–87 | 70.0 | 47 hip, 40 knee | M, IOF, CFU | 40/25 |
von Rothenburg et al. [52] | 2004 | Retrospective | 38 | 9/29 | 45–81 | 71.0 | 26 hip, 12 knee | M, IOF, A, L | 12/4 |
Iyengar & Vinjamuri [15] | 2005 | Retrospective | 38 | 18/20 | 54–89 | NR | 17 hip, 13 knee, 8 other | M, IOF, A, I, CFU | 13/2 |
Stumpe et al. [44] | 2006 | Prospective | 28 | 13/15 | 50–86 | 67.0/59.0 | 28 knee | M, CFU | 28/3 |
Rubello et al. [40] | 2008 | Prospective | 78 | 27/51 | 49–81 | 5.0 | 78 knee | M, CFU | 78/41 |
Mayer-Wagner et al. [23] | 2010 | NR | 32 | 13/19 | 45–90 | NR | 30 hip, 44 knee | M | 16/7 |
Fuster et al. [9] | 2011 | Prospective | 40 | 14/26 | NR | 66.0 | 21 hip, 16 knee, 3 shoulder | M, IOF, CFU | 16/6 |
Jung et al. [17] | 2012 | Prospective | 11 | 2/9 | NR | 72.0 | 11 knee | M, H, IOF, CFU | 11/5 |
Basu et al. [2] | 2014 | Prospective | 87 | 35/52 | 32–83 | 57.0 | 134 hip, 87 knee | M, H, IOF | 87/19 |
Kim et al. [18] | 2014 | Retrospective | 164 | 53/111 | 17–82 | 65.0 | 71 hip, 93 knee | M, H, IOF, CFU, A | 93/63 |
Granados et al. [12] | 2015 | Prospective | 120 | 50/70 | NR | 71.0 | 63 hip, 57 knee | M, CFU | 57/8 |